Big Pharma Faces Cell And Gene Therapy Market Realities
Real-World Challenges For Novel Products
Big pharma executives at ARM’s Cell and Gene Meeting on the Mesa shared some of the practical challenges of bringing one-time treatments to market in hemophilia, cancer and beyond.
